QCM
LEGN icon

Quantinno Capital Management’s Legend Biotech LEGN Stock Holding History

Quantinno Capital Management’s Portfolio LEGN Stock Details LEGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.36M Buy
81,596
+43,809
+116% +$1.18M ﹤0.01% 1835
2026
Q1 		$684K Buy
+37,787
New +$720K ﹤0.01% 2476
2025
Q4 		– Sell
-12,388
Closed -$404K – 3194
2025
Q3 		$404K Buy
12,388
+1,628
+15% +$60.1K ﹤0.01% 2206
2025
Q2 		$382K Sell
10,760
-324
-3% -$10.5K ﹤0.01% 1840
2025
Q1 		$376K Buy
+11,084
New +$398K ﹤0.01% 1507

Other funds holding LEGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.56% 1-Year Est. Return

Quantinno Capital Management's LEGN Position: Q2 2026 in Review

Quantinno Capital Management increased its Legend Biotech (LEGN) stake by 116% in Q2 2026, buying an estimated $1.18M and bringing the position to 81,596 shares worth $2.36M. The position accounts for ﹤0.01% of the portfolio, ranked #1835.

Quantinno Capital Management first reported a position in LEGN in Q1 2025 and has held it in 5 quarters since. 219 funds tracked by Wall St. Rank hold LEGN as of Q2 2026.

  • Quantinno Capital Management held 81,596 shares of Legend Biotech worth $2.36M as of Q2 2026.
  • Quantinno Capital Management bought 43,809 Legend Biotech shares in Q2 2026, an estimated $1.18M.
  • Legend Biotech made up ﹤0.01% of Quantinno Capital Management's portfolio in Q2 2026, its #1835 holding.
  • Quantinno Capital Management first reported a position in Legend Biotech in Q1 2025 and has held it in 5 quarters since.
  • 219 funds tracked by Wall St. Rank held Legend Biotech as of Q2 2026.

Based on Quantinno Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.